Free Trial

LexaGene (LXG) News Today

C$0.10
-0.03 (-19.23%)
(As of 02/21/2023)
Pamapol Ord Share Price (0LXG)
Biosynex SA ALBIO
Cyclopharm Ltd CYC
Lexagene Holdings Inc (LXGh)
IIROC Trading Halt - LXG
LexaGene Announces MiQLab® Sys - GuruFocus.com
LexaGene : OTCQB Cert - Marketscreener.com
LexaGene Reduces Time-to-Result by ~35% - GlobeNewswire
LexaGene Provides MCTO Update - GlobeNewswire
Get LexaGene News Delivered to You Automatically

Sign up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter.

This TSLA short trade is on a nine win hot streak (Ad)

Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.

But I can promise that you’ll see all the details for yourself here.

LXG Media Mentions By Week

LXG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LXG
News Sentiment

0.00

0.62

Average
Medical
News Sentiment

LXG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LXG Articles
This Week

0

0

LXG Articles
Average Week

Get LexaGene News Delivered to You Automatically

Sign up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (CVE:LXG) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners